EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies

Ye Yuan, Liang Li, Justin Earp, Lian Ma, Venkatesh Atul Bhattaram, Vishnu Sharma, Alexander Tong, Yaning Wang, Jiang Liu, Hao Zhu

The Journal of Clinical Pharmacology · 2024

DOI: 10.1002/jcph.2418 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Pharmacology, 2024. Verfasst von Ye Yuan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. Hauptthemen laut MEDLINE: RNA, Small Interfering, Drug Development. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The application of model‐informed drug development (MIDD) has revolutionized drug development and regulatory decision making, transforming the process into one that is more efficient, effective, and patient centered. A critical application of MIDD is to facilitate dose selection and optimization, which play a pivotal role in improving efficacy, safety, and tolerability profiles of a candidate drug. With the surge of interest in small interfering RNA (siRNA) drugs as a promising class of therapeutics, their applications in various disease areas have been extensively studied preclinically. However, dosing selection and optimization experience for siRNA in humans is limited. Unique challenges exist for the dose evaluation of siRNA due to the temporal discordance between pharmacokinetic and pharmacodynamic profiles, as well as limited available clinical experience and considerable interindividual variability. This review highlights the pivotal role of MIDD in facilitating dose selection and optimization for siRNA therapeutics. Based on past experiences with approved siRNA products, MIDD has demonstrated its ability to aid in dose selection for clinical trials and enabling optimal dosing for the general patient population. In addition, MIDD presents an opportunity for dose individualization based on patient characteristics, enhancing the precision and effectiveness of siRNA therapeutics. In conclusion, the integration of MIDD offers substantial advantages in navigating the complex challenges of dose selection and optimization in siRNA drug development, which in turn accelerates the development process, supports regulatory decision making, and ultimately improves the clinical outcomes of siRNA‐based therapies, fostering advancements in precision medicine across a diverse range of diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingDrug DevelopmentHumansModels, BiologicalAnimalsDose-Response Relationship, Drug

Stichwörter der Autor:innen

PK/PDdose selection and optimizationmodel‐informed drug development (MIDD)population PKsiRNA

Substanzen

RNA, Small Interfering

Autor:innen und Institutionen

  • Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

Zitieren

APA

Yuan, Y., Li, L., Earp, J., Ma, L., Bhattaram, V. A., Sharma, V., Tong, A., Wang, Y., Liu, J., & Zhu, H. (2024). Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2418

Vancouver

Yuan Y, Li L, Earp J, Ma L, Bhattaram VA, Sharma V, et al. Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies. The Journal of Clinical Pharmacology. 2024. doi:10.1002/jcph.2418

BibTeX
@article{Yuan2024,
  author = {Yuan, Ye and Li, Liang and Earp, Justin and Ma, Lian and Bhattaram, Venkatesh Atul and Sharma, Vishnu and Tong, Alexander and Wang, Yaning and Liu, Jiang and Zhu, Hao},
  title = {Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies},
  journal = {The Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1002/jcph.2418}
}
Kostenlos starten →